Sono‐Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono‐Immunotherapy of Head and Neck Squamous Cell Carcinoma
Advanced Materials · 2023-07 · 35 (30)
DOI: 10.1002/adma.202300854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 17.06.2023. Verfasst von Jianli Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry & Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China. Hauptthemen laut MEDLINE: Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key R & D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Immunotherapy has offered new opportunities to treat head and neck squamous cell carcinoma (HNSCC); however, its clinical applications are hindered by modest therapeutic outcomes and the “always‐on” pharmacological activity of immunomodulatory agents. Strategies for precise spatiotemporal activation of antitumor immunity can tackle these issues but remain challenging. Herein, a semiconducting polymeric nanoagonist (SPNM) with in situ sono‐activatable immunotherapeutic effects for precision sono‐immunotherapy of HNSCC is reported. SPNM is self‐assembled from a sonodynamic semiconducting polymer core conjugated with a stimulator of interferon genes (STING) agonist (MSA‐2) via a singlet oxygen cleavable linker. Under sono‐irradiation, SPNM produces singlet oxygen not only to eradicate tumor cells to trigger immunogenic cell death but also to unleash caged STING agonists via the cleavage of diphenoxyethene bonds for in situ activation of the STING pathway in the tumor region. Such sono‐driven STING activation mediated by SPNM promotes effector T cell infiltration and potentiates systemic antitumor immunity, eventually leading to tumor growth inhibition and long‐term immunological memory. This study thus presents a promising strategy for the precise spatiotemporal activation of cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry & Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.
- Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
ORCID-Profile: Xu Zhen
Förderung
- National Key R & D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- State Key Laboratory of Analytical Chemistry for Life Science
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Jiang, J., Zhang, M., Lyu, T., Chen, L., Wu, M., Li, R., Li, H., Wang, X., Jiang, X., & Zhen, X. (2023). Sono‐Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono‐Immunotherapy of Head and Neck Squamous Cell Carcinoma. Advanced Materials, 35(30). https://doi.org/10.1002/adma.202300854
Vancouver
Jiang J, Zhang M, Lyu T, Chen L, Wu M, Li R, et al. Sono‐Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono‐Immunotherapy of Head and Neck Squamous Cell Carcinoma. Advanced Materials. 2023;35(30). doi:10.1002/adma.202300854
BibTeX
@article{Jiang2023,
author = {Jiang, Jianli and Zhang, Miaomiao and Lyu, Tao and Chen, Linrong and Wu, Min and Li, Ruowei and Li, Haoze and Wang, Xiang and Jiang, Xiqun and Zhen, Xu},
title = {Sono‐Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono‐Immunotherapy of Head and Neck Squamous Cell Carcinoma},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {30},
doi = {10.1002/adma.202300854}
}
EUVIMED